Amneal Pharmaceuticals, Inc. (AMRX) Insider Trading

Name: Amneal Pharmaceuticals, Inc. (AMRX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 21, 2026): J. Kevin Buchi (Director): Gift of 20,445 shares.

Get alerted when insiders trade AMRX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta